Standard Life has reported a 56% increase in sales for its international bond in 2024, alongside new panel partnerships for the bond product with 7IM, Nucleus and Parmenion while additionally building on its long-standing arrangement with the Elevate platform.
This comes in the aftermath of the proposed IHT reforms announced in the Autumn Statement, that has seen advisers increasingly looking to incorporate offshore bond solutions into client portfolios as an efficient way of passing on assets.
Standard Life research found that 58% of IFAs have re-evaluated the role that offshore bonds could play in client plans following the autumn announcement.
Available across the four platforms as part of a General Investment Account, (GIA), these panel position widen the reach of Standard Life’s International Bond and increase its accessibility to advisers and their clients.
Warren Bright, head of retail intermediary and private client distribution at Standard Life, said: “With significant IHT changes anticipated in coming years, the opportunities to further protect clients and provide tax efficient returns has put offshore investing front and centre with advisers and their UK clients.
“We have been steadily building our presence in the offshore market with our International Bond spearing heading our approach. Securing panel positions with key platform providers is central to our strategy and opens up the benefits of offshore investing to a wider audience of retail investors.
“A significant plus for advisers using the 7IM, Nucleus and Parmenion Platforms to access International Bond is the ability to seamless align a client’s existing investment strategies with a single account.”
Standard Life further said is actively pursuing further platform opportunities as it builds out its offshore business with UK advisers and their clients.
